EQUITY RESEARCH MEMO

AutoCruitment

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)75/100

AutoCruitment is a San Francisco-based digital health company leveraging AI and machine learning to streamline patient recruitment for clinical trials. Founded in 2019, its platform combines a vast digital advertising network with automated pre-screening and referral to directly target and qualify patients for research sites. By reducing enrollment timelines and site burden across multiple therapeutic areas globally, AutoCruitment addresses a critical bottleneck in clinical development. The company operates in a high-demand market, as patient recruitment remains a top challenge for sponsors and CROs. With its technology-enabled approach, AutoCruitment is well-positioned to capture market share, though financial details and stage remain undisclosed.

Upcoming Catalysts (preview)

  • Q3 2026Major partnership with top-10 pharma or large CRO50% success
  • Q4 2026New therapeutic area expansion (e.g., oncology or rare disease)65% success
  • Q3 2026Series A or B funding round announcement40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)